Inventor · Foster City, CA, US

Scott E. Lazerwith

53Patents
11h-index
133Co-inventors
77Inventor score

Filing activity: Oct 18, 2007 → Jun 14, 2024

Most-cited inventions

PatentTitleAreaCited byStatus
US8088368B2 Antiviral compounds Chemistry; Metallurgy 57 Active
US9216996B2 Substituted 2,3,4,5,7,9,13,13a-octahydropyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazepines and methods for treating viral infections Chemistry; Metallurgy 43 Active
US8273341B2 Antiviral compounds Chemistry; Metallurgy 33 Active
US9951043B2 Therapeutic compounds Chemistry; Metallurgy 27 Active
US8884030B2 Inhibitors of Flaviviridae viruses Emerging Cross-Sectional Technologies 21 Active
US8524764B2 Inhibitors of Flaviviridae viruses Emerging Cross-Sectional Technologies 20 Active
US9522912B2 Polycyclic-carbamoylpyridone compounds and their pharmaceutical use Chemistry; Metallurgy 19 Active
US8575118B2 Antiviral compounds Chemistry; Metallurgy 16 Active
US9682084B2 Crystalline forms of (2R,5S,13AR)-8-hydroxy-7,9,-dioxo-N-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide Emerging Cross-Sectional Technologies 16 Active
US9376441B2 Substituted pyrrolidines as SYK inhibitors Chemistry; Metallurgy 13 Active
US8536187B2 2,4,6-trisubstituted pyrido(3,2-d)pyrimidines useful for treating viral infections Human Necessities 11 Active
US8841278B2 Antiviral compounds Chemistry; Metallurgy 11 Active
US10703733B2 MCL-1 inhibitors Human Necessities 10 Active
US9663528B2 Substituted 1,2,3,4,6,8,12,12a-octahydro-1,4-methanodipyrido[1,2-a:1',2'-d]pyrazines and methods for treating viral infections Chemistry; Metallurgy 10 Active
US9732092B2 Substituted 2,3,4,5,7,9,13,13a-octahydropyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]OXAZEPINES and methods for treating viral infections Chemistry; Metallurgy 10 Active
US10035809B2 Substituted 2,3,4,5,7,9,13,13a-octahydro-1,5-methanopyrido[1′,2′:4,5]pyrazino[1,2-a][1,3]diazepines and methods for treating viral infections Chemistry; Metallurgy 9 Active
US10988451B2 MCL-1 inhibitors Human Necessities 9 Active
US8822430B2 Antiviral compounds Chemistry; Metallurgy 8 Active
US9630978B2 Polycyclic-carbamoylpyridone compounds and their pharmaceutical use Chemistry; Metallurgy 8 Active
US10098886B2 Crystalline forms of (2R,5S,13AR)-8-hydroxy-7,9-dioxo-N-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13A- octahydro-2,5-methanopyrido[1′,2′:4,5]pyrazino[2,1-B] [1,3] oxazepine-10-carboxamide Emerging Cross-Sectional Technologies 7 Active
US11680064B2 Capsid inhibitors for the treatment of HIV Chemistry; Metallurgy 7 Active
US9511056B2 Antiviral compounds Chemistry; Metallurgy 6 Active
US8513298B2 Inhibitors of flaviviridae viruses Emerging Cross-Sectional Technologies 5 Active
US10005774B2 Syk inhibitors Chemistry; Metallurgy 4 Active
US10836769B2 Substituted pyrrolizine compounds and uses thereof Human Necessities 4 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.